|
|
|
Intellipharmaceutics International Inc (IPCIF) |
|
Intellipharmaceutics International Inc
IPCIF's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Intellipharmaceutics International Inc growth rates, revenue grew
in the fourth quarter of 2022 from the same quarter a year ago.
Ranking at No. 3889
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -2.27 %
Intellipharmaceutics International Inc net loss decreased from $-5 millions, to $-3 millions in fourth quarter of 2022,
• More on IPCIF's Growth
|
|
Intellipharmaceutics International Inc
reported net loss of -3 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.87.
• More on IPCIF's Valuation
|
|
|
|
|
Intellipharmaceutics International Inc
reported net loss of -3 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.87.
| | | |
